메뉴 건너뛰기
BJU International
Volumn 107, Issue 12, 2011, Pages 1893-1898
C-reactive protein is a strong predictor for anaemia in renal cell carcinoma: Role of IL-6 in overall survival
Author keywords

anaemia; c reactive protein; interleukin 6; renal cell carcinoma; survival
Indexed keywords

C REACTIVE PROTEIN; ERYTHROPOIETIN; HEMOGLOBIN; INTERLEUKIN 6; LACTATE DEHYDROGENASE; NEOPTERIN;
EID: 79957817966     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09817.x     Document Type: Article
Times cited : (26)
References (52)
  • 2
    • 0013954846 scopus 로고
    • The anemia of chronic disorders
    • Cartwright GE,. The anemia of chronic disorders. Semin Hematol 1966; 3: 351-75
    • (1966) Semin Hematol , vol.3 , pp. 351-375
    • Cartwright, G.E.1
  • 3
    • 33745121783 scopus 로고
    • Medical aspects of renal carcinoma
    • Pinals RS, Krane SM,. Medical aspects of renal carcinoma. Postgrad Med J 1962; 38: 507-19
    • (1962) Postgrad Med J , vol.38 , pp. 507-519
    • Pinals, R.S.1    Krane, S.M.2
  • 4
  • 5
    • 0017638289 scopus 로고
    • Systemic effects of hypernephroma
    • DOI 10.1016/0090-4295(77)90001-2
    • Cherukuri SV, Johenning PW, Ram MD,. Systemic effects of hypernephroma. Urology 1977; 10: 93-7 (Pubitemid 8163783)
    • (1977) Urology , vol.10 , Issue.2 , pp. 93-97
    • Cherukuri, S.V.1    Johenning, P.W.2    Ram, M.D.3
  • 6
    • 39549105788 scopus 로고    scopus 로고
    • Association of Abnormal Preoperative Laboratory Values with Survival After Radical Nephrectomy for Clinically Confined Clear Cell Renal Cell Carcinoma
    • DOI 10.1016/j.urology.2007.08.048, PII S0090429507020717
    • Magera JS Jr, Leibovich BC, Lohse CM, et al,. Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinoma. Urology 2008; 71: 278-82 (Pubitemid 351282342)
    • (2008) Urology , vol.71 , Issue.2 , pp. 278-282
    • Magera Jr., J.S.1    Leibovich, B.C.2    Lohse, C.M.3    Sengupta, S.4    Cheville, J.C.5    Kwon, E.D.6    Blute, M.L.7
  • 7
    • 0031228854 scopus 로고    scopus 로고
    • Current prognostic factors - Renal cell carcinoma: Workgroup No. 4. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)
    • Srigley JR, Hutter RV, Gelb AB, et al,. Current prognostic factors-renal cell carcinoma: workgroup No. 4. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80: 994-6
    • (1997) Cancer , vol.80 , pp. 994-996
    • Srigley, J.R.1    Hutter, R.V.2    Gelb, A.B.3
  • 8
    • 14744278436 scopus 로고    scopus 로고
    • Anemia of chronic disease
    • Weiss G, Goodnough LT,. Anemia of chronic disease. N Engl J Med 2005; 352: 1011-23
    • (2005) N Engl J Med , vol.352 , pp. 1011-1023
    • Weiss, G.1    Goodnough, L.T.2
  • 9
    • 67149084949 scopus 로고    scopus 로고
    • Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: Diagnostic and therapeutic implications
    • Theurl I, Aigner E, Theurl M, et al,. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009; 113: 5277-86
    • (2009) Blood , vol.113 , pp. 5277-5286
    • Theurl, I.1    Aigner, E.2    Theurl, M.3
  • 10
    • 42949127743 scopus 로고    scopus 로고
    • Anaemia of cancer: An overview of mechanisms involved in its pathogenesis
    • Grotto HZ,. Anaemia of cancer: an overview of mechanisms involved in its pathogenesis. Med Oncol 2008; 25: 12-21
    • (2008) Med Oncol , vol.25 , pp. 12-21
    • Grotto, H.Z.1
  • 12
    • 0035896642 scopus 로고    scopus 로고
    • Hepcidin, a urinary antimicrobial peptide synthesized in the liver
    • Park CH, Valore EV, Waring AJ, Ganz T,. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 2001; 276: 7806-10
    • (2001) J Biol Chem , vol.276 , pp. 7806-7810
    • Park, C.H.1    Valore, E.V.2    Waring, A.J.3    Ganz, T.4
  • 13
    • 0041672570 scopus 로고    scopus 로고
    • Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
    • DOI 10.1182/blood-2003-03-0672
    • Ganz T,. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003; 102: 783-8 (Pubitemid 36917762)
    • (2003) Blood , vol.102 , Issue.3 , pp. 783-788
    • Ganz, T.1
  • 14
    • 33748581212 scopus 로고    scopus 로고
    • Hepcidin - The iron regulatory hormone
    • Rossi E,. Hepcidin-the iron regulatory hormone. Clin Biochem Rev 2005; 26: 47-9
    • (2005) Clin Biochem Rev , vol.26 , pp. 47-49
    • Rossi, E.1
  • 15
    • 0033863852 scopus 로고    scopus 로고
    • Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: Clinical and biologic effects
    • Olencki T, Finke J, Tubbs R, et al,. Phase 1 trial of subcutaneous IL-6 in patients with refractory cancer: clinical and biologic effects. J Immunother 2000; 23: 549-56
    • (2000) J Immunother , vol.23 , pp. 549-556
    • Olencki, T.1    Finke, J.2    Tubbs, R.3
  • 16
    • 0029112458 scopus 로고
    • Interleukin-6-associated anemia: Determination of the underlying mechanism
    • Atkins MB, Kappler K, Mier JW, Isaacs RE, Berkman EM,. Interleukin-6-associated anemia: determination of the underlying mechanism. Blood 1995; 86: 1288-91
    • (1995) Blood , vol.86 , pp. 1288-1291
    • Atkins, M.B.1    Kappler, K.2    Mier, J.W.3    Isaacs, R.E.4    Berkman, E.M.5
  • 17
    • 0029096426 scopus 로고
    • Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients
    • Nieken J, Mulder NH, Buter J, et al,. Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients. Blood 1995; 86: 900-5
    • (1995) Blood , vol.86 , pp. 900-905
    • Nieken, J.1    Mulder, N.H.2    Buter, J.3
  • 19
    • 0027978341 scopus 로고
    • Effects of recombinant human interleukin-6 in cancer patients: A phase I-II study
    • van Gameren MM, Willemse PH, Mulder NH, et al,. Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study. Blood 1994; 84: 1434-41
    • (1994) Blood , vol.84 , pp. 1434-1441
    • Van Gameren, M.M.1    Willemse, P.H.2    Mulder, N.H.3
  • 23
    • 0030902413 scopus 로고    scopus 로고
    • Prognostic factors for survival in metastatic renal cell carcinoma: Retrospective analysis from 109 consecutive patients
    • Citterio G, Bertuzzi A, Tresoldi M, et al,. Prognostic factors for survival in metastatic renal cell carcinoma: retrospective analysis from 109 consecutive patients. Eur Urol 1997; 31: 286-91 (Pubitemid 27156376)
    • (1997) European Urology , vol.31 , Issue.3 , pp. 286-291
    • Citterio, G.1    Bertuzzi, A.2    Tresoldi, M.3    Galli, L.4    Di Lucca, G.5    Scaglietti, U.6    Rugarli, C.7
  • 24
    • 0030791061 scopus 로고    scopus 로고
    • Renal cell carcinoma: Current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)
    • Gelb AB,. Renal cell carcinoma: current prognostic factors. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997; 80: 981-6
    • (1997) Cancer , vol.80 , pp. 981-986
    • Gelb, A.B.1
  • 25
    • 0031748713 scopus 로고    scopus 로고
    • Prognostic factors of renal cell carcinoma: A multivariate analysis
    • DOI 10.1002/(SICI)1096-9098(199805)68:1<11::AID-JSO4>3.0.CO;2-O
    • Yasunaga Y, Shin M, Miki T, Okuyama A, Aozasa K,. Prognostic factors of renal cell carcinoma: a multivariate analysis. J Surg Oncol 1998; 68: 11-8 (Pubitemid 28243862)
    • (1998) Journal of Surgical Oncology , vol.68 , Issue.1 , pp. 11-18
    • Yasunaga, Y.1    Shin, M.2    Miki, T.3    Okuyama, A.4    Aozasa, K.5
  • 26
    • 14344256112 scopus 로고    scopus 로고
    • The impact of anaemia on outcome in cancer
    • DOI 10.1111/j.1365-2257.2004.00664.x
    • Clarke H, Pallister CJ,. The impact of anaemia on outcome in cancer. Clin Lab Haematol 2005; 27: 1-13 (Pubitemid 40293371)
    • (2005) Clinical and Laboratory Haematology , vol.27 , Issue.1 , pp. 1-13
    • Clarke, H.1    Pallister, C.J.2
  • 27
    • 54049134838 scopus 로고    scopus 로고
    • Hypoxia and aggressive tumor phenotype: Implications for therapy and prognosis
    • Vaupel P,. Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis. Oncologist 2008; 13 (Suppl. 3): 21-6
    • (2008) Oncologist , vol.13 , Issue.3 SUPPL. , pp. 21-26
    • Vaupel, P.1
  • 28
    • 47249148397 scopus 로고    scopus 로고
    • Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1α in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up
    • Minardi D, Lucarini G, Filosa A, et al,. Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up. Int J Immunopathol Pharmacol 2008; 21: 447-55 (Pubitemid 351988410)
    • (2008) International Journal of Immunopathology and Pharmacology , vol.21 , Issue.2 , pp. 447-455
    • Minardi, D.1    Lucarini, G.2    Filosa, A.3    Milanese, G.4    Zizzi, A.5    Di Primio, R.6    Montironi, R.7    Muzzonigro, G.8
  • 31
    • 0026560592 scopus 로고
    • Interleukin-6 and renal cell cancer: Production, regulation, and growth effects
    • Koo AS, Armstrong C, Bochner B, et al,. Interleukin-6 and renal cell cancer: production, regulation, and growth effects. Cancer Immunol Immunother 1992; 35: 97-105
    • (1992) Cancer Immunol Immunother , vol.35 , pp. 97-105
    • Koo, A.S.1    Armstrong, C.2    Bochner, B.3
  • 32
    • 0025990509 scopus 로고
    • Interferon-gamma interrupts autocrine growth mediated by endogenous interleukin-6 in renal-cell carcinoma
    • Gruss HJ, Brach MA, Mertelsmann RH, Herrmann F,. Interferon-gamma interrupts autocrine growth mediated by endogenous interleukin-6 in renal-cell carcinoma. Int J Cancer 1991; 49: 770-3
    • (1991) Int J Cancer , vol.49 , pp. 770-773
    • Gruss, H.J.1    Brach, M.A.2    Mertelsmann, R.H.3    Herrmann, F.4
  • 35
    • 17644368573 scopus 로고    scopus 로고
    • Interleukin-6: From basic science to medicine - 40 Years in immunology
    • DOI 10.1146/annurev.immunol.23.021704.115806
    • Kishimoto T,. Interleukin-6: from basic science to medicine-40 years in immunology. Annu Rev Immunol 2005; 23: 1-21 (Pubitemid 40563163)
    • (2005) Annual Review of Immunology , vol.23 , pp. 1-21
    • Kishimoto, T.1
  • 36
    • 0025190892 scopus 로고
    • Interleukin-6 and the acute phase response
    • Heinrich PC, Castell JV, Andus T,. Interleukin-6 and the acute phase response. Biochem J 1990; 265: 621-36 (Pubitemid 20053863)
    • (1990) Biochemical Journal , vol.265 , Issue.3 , pp. 621-636
    • Heinrich, P.C.1    Castell, J.V.2    Andus, T.3
  • 37
    • 0038662619 scopus 로고    scopus 로고
    • Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
    • DOI 10.1182/blood-2002-10-3235
    • Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T,. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003; 101: 2461-3 (Pubitemid 36857598)
    • (2003) Blood , vol.101 , Issue.7 , pp. 2461-2463
    • Nemeth, E.1    Valore, E.V.2    Territo, M.3    Schiller, G.4    Lichtenstein, A.5    Ganz, T.6
  • 38
    • 0017652324 scopus 로고
    • Isolation of a peptido polysaccharide from the dermatophyte Epidermophyton floccosum and a study of its reaction with human C reactive protein and a mouse anti phosphorylcholine myeloma serum
    • Baldo BA, Fletcher TC, Pepys J,. Isolation of a peptido-polysaccharide from the dermatophyte Epidermophyton floccosum and a study of its reaction with human C-reactive protein and a mouse anti-phosphorylcholine myeloma serum. Immunology 1977; 32: 831-42 (Pubitemid 8120572)
    • (1977) Immunology , vol.32 , Issue.6 , pp. 831-842
    • Baldo, B.A.1    Fletcher, T.C.2    Pepys, J.3
  • 39
    • 0016748392 scopus 로고
    • Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations
    • Siegel J, Osmand AP, Wilson MF, Gewurz H,. Interactions of C-reactive protein with the complement system. II. C-reactive protein-mediated consumption of complement by poly-L-lysine polymers and other polycations. J Exp Med 1975; 142: 709-21
    • (1975) J Exp Med , vol.142 , pp. 709-721
    • Siegel, J.1    Osmand, A.P.2    Wilson, M.F.3    Gewurz, H.4
  • 40
    • 0016287015 scopus 로고
    • Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera
    • Siegel J, Rent R, Gewurz H,. Interactions of C-reactive protein with the complement system. I. Protamine-induced consumption of complement in acute phase sera. J Exp Med 1974; 140: 631-47
    • (1974) J Exp Med , vol.140 , pp. 631-647
    • Siegel, J.1    Rent, R.2    Gewurz, H.3
  • 41
    • 0020518031 scopus 로고
    • The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection
    • Nakayama S, Gewurz H, Holzer T, Du Clos TW, Mold C,. The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection. Clin Exp Immunol 1983; 54: 319-26 (Pubitemid 13018176)
    • (1983) Clinical and Experimental Immunology , vol.54 , Issue.2 , pp. 319-326
    • Nakayama, S.1    Gewurz, H.2    Holzer, T.3
  • 42
    • 0019787152 scopus 로고
    • C-reactive protein is protective against Streptococcus pneumoniae in mice
    • Mold C, Nakayama S, Holzer TJ, Gewurz H, Du Clos TW,. C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J Exp Med 1981; 154: 1703-8 (Pubitemid 12235210)
    • (1981) Journal of Experimental Medicine , vol.154 , Issue.5 , pp. 1703-1708
    • Mold, C.1    Nakayama, S.2    Holzer, T.J.3
  • 43
    • 0026625812 scopus 로고
    • Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma
    • Blay JY, Negrier S, Combaret V, et al. Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 1992; 52: 3317-22
    • (1992) Cancer Res , vol.52 , pp. 3317-3322
    • Blay, J.Y.1    Negrier, S.2    Combaret, V.3
  • 45
    • 0027972253 scopus 로고
    • Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma
    • Dosquet C, Schaetz A, Faucher C, et al. Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma. Eur J Cancer 1994; 30A: 162-7
    • (1994) Eur J Cancer , vol.30 A , pp. 162-167
    • Dosquet, C.1    Schaetz, A.2    Faucher, C.3
  • 47
    • 0026468475 scopus 로고
    • Serum interleukin-6 levels in metastatic renal cell cancer: Correlation with survival but not an independent prognostic indicator
    • Stadler WM, Richards JM, Vogelzang NJ,. Serum interleukin-6 levels in metastatic renal cell cancer: correlation with survival but not an independent prognostic indicator. J Natl Cancer Inst 1992; 84: 1835-6
    • (1992) J Natl Cancer Inst , vol.84 , pp. 1835-1836
    • Stadler, W.M.1    Richards, J.M.2    Vogelzang, N.J.3
  • 48
    • 0031415831 scopus 로고    scopus 로고
    • Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma
    • DOI 10.1016/S0959-8049(97)00179-2, PII S0959804997001792
    • Ljungberg B, Grankvist K, Rasmuson T,. Serum interleukin-6 in relation to acute-phase reactants and survival in patients with renal cell carcinoma. Eur J Cancer 1997; 33: 1794-8 (Pubitemid 28129206)
    • (1997) European Journal of Cancer , vol.33 , Issue.11 , pp. 1794-1798
    • Ljungberg, B.1    Grankvist, K.2    Rasmuson, T.3
  • 49
  • 51
    • 0033568576 scopus 로고    scopus 로고
    • Regulation of the erythropoietin gene
    • Ebert BL, Bunn HF,. Regulation of the erythropoietin gene. Blood 1999; 94: 1864-77 (Pubitemid 29430402)
    • (1999) Blood , vol.94 , Issue.6 , pp. 1864-1877
    • Ebert, B.L.1    Bunn, H.F.2
  • 52
    • 69249166103 scopus 로고    scopus 로고
    • Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma
    • Kamai T, Tomosugi N, Abe H, Arai K, Yoshida K,. Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma. BMC Cancer 2009; 9: 270
    • (2009) BMC Cancer , vol.9 , pp. 270
    • Kamai, T.1    Tomosugi, N.2    Abe, H.3    Arai, K.4    Yoshida, K.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.